4//SEC Filing
Recro Pharma, Inc. 4
Accession 0001123292-16-002562
CIK 0001588972operating
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 2:21 PM ET
Size
6.1 KB
Accession
0001123292-16-002562
Insider Transaction Report
Form 4
Mack Randall
Senior VP, Development
Transactions
- Exercise/Conversion
Common Stock
2016-08-01+6,100→ 8,100 total - Tax Payment
Common Stock
2016-08-01$9.70/sh−2,546$24,696→ 5,554 total
Footnotes (1)
- [F1]On August 1, 2016, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 6,100 performance-based restricted stock units, which were converted into 6,100 shares of common stock on a one-for-one basis.
Documents
Issuer
Recro Pharma, Inc.
CIK 0001588972
Entity typeoperating
IncorporatedPA
Related Parties
1- filerCIK 0001588972
Filing Metadata
- Form type
- 4
- Filed
- Aug 2, 8:00 PM ET
- Accepted
- Aug 3, 2:21 PM ET
- Size
- 6.1 KB